ORLANDO, Fla.—The leader of Gilead Sciences' Kite Pharma is sure that anito-cel, the biotech’s next-generation multiple myeloma CAR-T challenger to Carvykti, is ready for prime time—and that the ...
Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an effective cure for beta-thalassemia and sickle cell disease in children younger ...
Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Almost a quarter century ago today, the Xbox debuted one of its most distinct launch titles — and ...
Cel Critical Power to bring 250 jobs to James City County with new U.S. facility, says Gov. Youngkin
JAMES CITY COUNTY, Va. — CEL Critical Power, a global provider of power solutions, will invest $5.2 million to open its first American manufacturing facility in James City County, Governor Glenn ...
Scientist Kate Adamala doesn’t remember exactly when she realized her lab at the University of Minnesota was working on something potentially dangerous — so dangerous in fact that some researchers ...
Don’t come for the queen. Before being voted off “Survivor 49” after a tribe swap, Matt Williams shaded two-time winner Sandra Diaz-Twine by saying that he dislikes her infamous “anyone but me” ...
Julián F.L. is a Video Game & Anime expert, historian & journalist with a lot of passion for these subjects and over 10 years of experience in writing about them. He knows every single Pokémon by ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. As reported by Complex, social media sites like TikTok and X have repeatedly memed the final ...
Way is questionable to return to Sunday's game against the Giants due to a back injury, Zach Selby of the Commanders' official site reports. Way may have suffered the injury after hitting the ground ...
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the pricing of a best-efforts public ...
CEL-SCI Corporation (NYSE:CVM) shares tumbled 38.19% in after-hours trading to $8.06 on Tuesday following the cancer immunotherapy company’s announcement of a $10 million public offering priced below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback